Literature DB >> 12966163

Protease-activated receptors: new concepts in regulation of G protein-coupled receptor signaling and trafficking.

Joann Trejo1.   

Abstract

Most G protein-coupled receptors (GPCRs) are reversibly activated upon ligand binding. However, activation of protease-activated G protein-coupled receptors (PARs) occurs through an irreversible proteolytic event that results in the generation of a tethered ligand that cannot diffuse away. This unusual mode of PAR activation raises important questions regarding the mechanisms responsible for termination of receptor signaling. There are currently four members of the PAR family. Thrombin activates PAR1, PAR3, and PAR4, whereas multiple trypsin-like serine proteases activate PAR2. The regulation of signaling by PAR1 has been extensively studied, whereas considerably less is known about the other PARs. It has been demonstrated that rapid termination of PAR1 signaling is critical in determining the magnitude and kinetics of the cellular protease response. Therefore, elucidating the molecular mechanisms involved in the regulation of PAR signaling is essential to fully understand protease-mediated responses. Recent findings indicate that novel mechanisms contribute to PAR1 desensitization, internalization, and down-regulation. This review focuses on the intracellular mechanisms that regulate PAR signaling and the recent progress in developing inhibitors of PAR signaling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12966163     DOI: 10.1124/jpet.103.052100

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  39 in total

1.  A systems genetic analysis of alcohol drinking by mice, rats and men: influence of brain GABAergic transmission.

Authors:  Laura M Saba; Beth Bennett; Paula L Hoffman; Kelsey Barcomb; Takao Ishii; Katerina Kechris; Boris Tabakoff
Journal:  Neuropharmacology       Date:  2010-12-23       Impact factor: 5.250

2.  The antifibrotic effects of plasminogen activation occur via prostaglandin E2 synthesis in humans and mice.

Authors:  Kristy A Bauman; Scott H Wettlaufer; Katsuhide Okunishi; Kevin M Vannella; Joshua S Stoolman; Steven K Huang; Anthony J Courey; Eric S White; Cory M Hogaboam; Richard H Simon; Galen B Toews; Thomas H Sisson; Bethany B Moore; Marc Peters-Golden
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

3.  Neural transmembrane protease and endothelial Gs protein activation in cell contact-dependent signaling between neural stem/progenitor cells and brain endothelial cells.

Authors:  Hsiu-Hui Tung; Sheau-Ling Lee
Journal:  J Biol Chem       Date:  2012-05-10       Impact factor: 5.157

4.  Combined argatroban and anti-oxidative agents prevents increased vascular contractility to thrombin and other ligands after subarachnoid haemorrhage.

Authors:  Katsuharu Kameda; Yuichiro Kikkawa; Mayumi Hirano; Satoshi Matsuo; Tomio Sasaki; Katsuya Hirano
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

Review 5.  Thrombomodulin and its role in inflammation.

Authors:  Edward M Conway
Journal:  Semin Immunopathol       Date:  2011-07-31       Impact factor: 9.623

6.  Impaired feedback regulation of the receptor activity and the myofilament Ca2+ sensitivity contributes to increased vascular reactiveness after subarachnoid hemorrhage.

Authors:  Yuichiro Kikkawa; Katsuharu Kameda; Mayumi Hirano; Tomio Sasaki; Katsuya Hirano
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-17       Impact factor: 6.200

7.  Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans.

Authors:  Supriya Srinivasan; Cecile Lubrano-Berthelier; Cedric Govaerts; Franck Picard; Pamela Santiago; Bruce R Conklin; Christian Vaisse
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

8.  Thrombin-promoted release of UDP-glucose from human astrocytoma cells.

Authors:  S M Kreda; L Seminario-Vidal; C van Heusden; E R Lazarowski
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

9.  Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cells.

Authors:  Valérie Gratio; Nathalie Beaufort; Lina Seiz; Josefine Maier; G Duke Virca; Mekdes Debela; Nicolai Grebenchtchikov; Viktor Magdolen; Dalila Darmoul
Journal:  Am J Pathol       Date:  2010-01-07       Impact factor: 4.307

Review 10.  Progress in the understanding of protease-activated receptors.

Authors:  Esteban C Gabazza; Osamu Taguchi; Haruhito Kamada; Tatsuya Hayashi; Yukihiko Adachi; Koji Suzuki
Journal:  Int J Hematol       Date:  2004-02       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.